Cardiex Ltd (ASX:CDX) Share Price & Analysis
(ASX:CDX) Share Price Chart
About (ASX: CDX)
Cardiex is a pioneering health technology company that specializes in developing advanced digital biomarkers and solutions for cardiovascular health monitoring. Their innovative approach focuses on providing comprehensive vascular health insights through cutting-edge technologies like the FDA-cleared SphygmoCor® system, which replaces traditional blood pressure measurement methods with more precise arterial health screening techniques.
The company’s solutions are designed to empower multiple stakeholders in the healthcare ecosystem, including providers, researchers, clinical trial teams, and patients. By offering point-of-care arterial health screening and remote patient monitoring capabilities, Cardiex enables more informed treatment decisions, accelerates drug development, and helps individuals actively participate in their health management. Their technology can evaluate arterial health, identify disease risk, track progression, and assess the effectiveness of medical interventions.
Cardiex has established partnerships with numerous prestigious medical institutions and research centers, including UCSF Medical Center, Mayo Clinic, Stanford Medicine, and pharmaceutical companies like AstraZeneca and Novartis. Their commitment to advancing cardiovascular health is evident through initiatives like the CARTESIAN Study, which explores the vascular consequences of COVID-19, demonstrating their dedication to using digital biomarkers to enhance medical understanding and patient care across various health conditions.